Top 3 Genomic Sequencing Stocks To Buy On The Rebound

Looking out into 2021 current consensus estimates call for growth to re-accelerate to 52% ($150 million) and adjusted EPS loss of -$1.74. 

1 2 3 4
View single page >> |

Disclaimer: All the information in this article - is published in good faith and for general information purpose only. Hashtag Investing does not make any warranties about the completeness, ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.